Patents Assigned to Pro-Virus, Inc.
  • Treatment of neoplasms with viruses
    Publication number: 20080057037
    Abstract: The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.
    Type: Application
    Filed: January 29, 2007
    Publication date: March 6, 2008
    Applicant: Pro-Virus, Inc.
    Inventors: Michael Roberts, Robert Lorence, William Groene, Harvey Rabin, Reid von Borstel
  • Treatment of neoplasms with viruses
    Publication number: 20030165465
    Abstract: The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.
    Type: Application
    Filed: June 13, 2002
    Publication date: September 4, 2003
    Applicant: Pro-Virus, inc.
    Inventors: Michael S. Roberts, Robert M. Lorence, William S. Groene, Harvey Rabin, Reid W. von Borstel
  • Treatment of neoplasms with viruses
    Publication number: 20030044384
    Abstract: The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection, design, purification and use of such viruses for cancer therapy.
    Type: Application
    Filed: January 15, 2002
    Publication date: March 6, 2003
    Applicant: Pro-Virus, Inc.
    Inventors: Michael S. Roberts, Robert M. Lorence, William S. Groene, Harvey Rabin, Reid W. von Borstel
  • Use of neuro-derived fetal cell lines for transplantation therapy
    Publication number: 20020110546
    Abstract: Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
    Type: Application
    Filed: October 10, 2001
    Publication date: August 15, 2002
    Applicant: Pro-Virus, Inc.
    Inventors: Eugene O. Major, Carlo S. Tornatore, Kris Bankiewicz